Projects per year
Personal profile
Research Statement
The Stratified Medicine Group focuses on the following areas:
1) Characterisation of a molecular group in solid cancers that represents an innate immune response to DNA damage through the STING pathway.
2) Development of a biomarker for anti-angiogenic agents
3) Development of a biomarker for MEKK pathway activation
4) Identification of a prognostic biomarker for early prostate cancer
5) Development of new cell lines for pre-clinical modelling of ovarian and prostate cancer.
Other
Linked in Profile:
https://www.linkedin.com/in/profkennedy/
Fingerprint Dive into the research topics where Richard Kennedy is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 76 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
R1005PMY: Artificial Intelligence Enables Clinical Decision Making in the Digital Healthcare Era
McArt, D., Kennedy, R. & Salto-Tellez, M.
12/02/2019 → …
Project: Research
R1523CNR: “S-CORT: Stratification in COloRectal cancer: from biology to Treatment prediction”.
Lawler, M., Johnston, P., Kennedy, R., Salto-Tellez, M. & Wilson, R.
29/04/2015 → …
Project: Research
R6416CNR: Phase 1B/II study of MEK1/2 inhibitor PD-0325901 with cMET inhibitor PF-02341066 in KRASMT and KRASWT (with aberrant c-MET) Colorectal Cancer Patients
Van Schaeybroeck, S., Johnston, P., Kennedy, R., Lawler, M., Longley, D., Salto-Tellez, M. & Wilson, R.
01/08/2013 → …
Project: Research
R2116CNR: MOVEMBER CENTRE OF EXCELLENCE
O'Sullivan, J., Jain, S., Kennedy, R., McDade, S., Prise, K., Salto-Tellez, M. & Waugh, D.
21/05/2014 → 30/06/2019
Project: Research
Research Output
Identification of Src’s role in governing chemotherapy resistance in oesophageal adenocarcinoma through functional genomic and high-throughput drug screening approaches
McCabe, N., Stevenson, L., Scanlon, E., Keminer, O., Kennedy, R., Windshuegel, B., Blayney, J. & Turkington, R., 22 Jun 2020.Research output: Contribution to conference › Abstract
A Novel Role for Cathepsin S as a Potential Biomarker in Triple Negative Breast Cancer
Wilkinson, R., Burden, R., McDowell, S., McArt, D., McQuaid, S., Bingham, V., Williams, R., Cox, O., O'Connor, R., McCabe, N., Kennedy, R., Buckley, N. E. & Scott, C., 28 Jun 2019, In : Journal of Oncology.Research output: Contribution to journal › Article
Open Access
File
3
Citations
(Scopus)
99
Downloads
(Pure)
Defining an IBD-like subgroup in consensus molecular subgroups of colorectal cancer and transcriptomic biomarker development for at-risk patients.
Scanlon, E., Murphy, S. J., Kennedy, R. D. & Blayney, J. K., 26 May 2019, In : Journal of Clinical Oncology : official journal of the American Society of Clinical Oncology. 37, 15_supplResearch output: Contribution to journal › Meeting abstract
Defining the molecular evolution of extrauterine high grade serous carcinoma
Beirne, J. P., McArt, D. G., Roddy, A., McDermott, C., Ferris, J., Buckley, N. E., Coulter, P., McCabe, N., Eddie, S. L., Dunne, P. D., O'Reilly, P., Gilmore, A., Feeney, L., Ewing, D. L., Drapkin, R. I., Salto-Tellez, M., Kennedy, R. D., Harley, I. J. G., McCluggage, W. G. & Mullan, P. B., 04 Sep 2019, In : Gynecologic Oncology. 155, 2, p. 305-317 13 p.Research output: Contribution to journal › Article
1
Citation
(Scopus)
DNA Repair Deficiency in Breast Cancer: Opportunities for Immunotherapy
Gilmore, E., McCabe, N., Kennedy, R. & Parkes, E., 19 Jun 2019, In : Journal of Oncology.Research output: Contribution to journal › Article
Open Access
File
4
Citations
(Scopus)
145
Downloads
(Pure)
Prizes
Queen’s University of Belfast Vice Chancellor Award for Innovation
Kennedy, Richard (Recipient), 2013
Prize: Prize (including medals and awards)
St Luke’s Medal for Cancer Research. Royal College of Medicine, Ireland
Kennedy, Richard (Recipient), 2015
Prize: Prize (including medals and awards)
Press / Media
Behind the Science. 30 minute TV programme on Cancer Research at QUB/Almac
13/12/2017
1 Media contribution
Press/Media: Public Engagement Activities
A visit to the Doctor in 2013. Public lecture.
10/10/2017
1 item of Media coverage
Press/Media: Public Engagement Activities
Impact
Development and Commercialization of a Technology Platform to Enable Biomarker Discovery and Validation
Richard Kennedy (Participant), Paul Harkin (Participant), Patrick Johnston (Participant), Alison Hosey (Participant), Julia Miskelly (Participant), Margaret Murray (Participant), Jennifer Quinn (Participant), Colin James (Participant), Jude Mulligan (Participant), Peter Daly (Participant), Paul Mullan (Participant), Julie Mussen (Participant), Ultan McDermott (Participant), Richard Wilson (Participant) & Daniel Longley (Participant)
Impact: Health Impact, Quality of Life Impact
Thesis
Molecular Biology of AKT Inhibition in Gastro-oesophageal Adenocarcinoma
Author: Cairns, L., Jul 2019Supervisor: Turkington, R. (Supervisor), Kennedy, R. (Supervisor) & Harrison, T. (Supervisor)
Student thesis: Doctoral Thesis › Doctor of Philosophy